139 related articles for article (PubMed ID: 15667911)
1. Correlation between levels of tumour necrosis factor-alpha and levels of pH, glucose, and lactate dehydrogenase in parapneumonic effusions.
Odeh M; Sabo E; Srugo I; Oliven A
J Infect; 2005 Feb; 50(2):114-9. PubMed ID: 15667911
[TBL] [Abstract][Full Text] [Related]
2. Correlation between polymorphonuclear leukocyte counts and levels of tumor necrosis factor-a in pleural fluid of patients with parapneumonic effusion.
Odeh M; Sabo E; Srugo I; Oliven A
Lung; 2002; 180(5):265-71. PubMed ID: 12489020
[TBL] [Abstract][Full Text] [Related]
3. The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.
Odeh M; Makhoul B; Sabo E; Srugo I; Oliven A
Lung; 2005; 183(1):13-27. PubMed ID: 15793664
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor-alpha in the differential diagnosis of parapneumonic effusion.
Odeh M; Sabo E; Oliven A; Srugo I
Int J Infect Dis; 2000; 4(1):38-41. PubMed ID: 10689213
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-8 in differentiation of uncomplicated from complicated parapneumonic effusion.
Petrusevska Marinkovic S; Kondova Topuzovska I; Milenkovic Z; Kondov G; Bosevska G; Anastasovska A
Prilozi; 2011; 32(1):101-11. PubMed ID: 21822181
[TBL] [Abstract][Full Text] [Related]
7. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
8. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
[TBL] [Abstract][Full Text] [Related]
9. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
11. Childhood parapneumonic effusions: biochemical and inflammatory markers.
Utine GE; Ozcelik U; Yalcin E; Dogru D; Kiper N; Aslan A; Kanra G
Chest; 2005 Sep; 128(3):1436-41. PubMed ID: 16162740
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
13. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
14. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
15. The glucose-pH relationship in parapneumonic effusions.
Potts DE; Taryle DA; Sahn SA
Arch Intern Med; 1978 Sep; 138(9):1378-80. PubMed ID: 28707
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.
Zaga T; Makris D; Tsilioni I; Kiropoulos T; Oikonomidi S; Damianos A; Gourgoulianis KI
Monaldi Arch Chest Dis; 2011 Sep; 75(3):167-71. PubMed ID: 22428219
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
19. Parapneumonic effusions.
Light RW; Girard WM; Jenkinson SG; George RB
Am J Med; 1980 Oct; 69(4):507-12. PubMed ID: 7424940
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of C-Reactive Protein in Discrimination between Uncomplicated and Complicated Parapneumonic Effusion.
Kogan Y; Sabo E; Odeh M
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33076437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
